SEARCH RESULTS FOR:
Climate Change Adaptation
Chile Mining 2024 - Digital Interactive
Engineering, consulting and construction firms prepare Chile's mines for the future
Andy Ang
MANAGING DIRECTOR ASIA PACIFIC (APAC), ROYAL DEN HARTOGH LOGISTICS
"We recognized the APAC to be an epicenter for chemicals growth."
Jian Min (Edmund) Sim
FOUNDER, SOURCESAGE
"By combining greater volumes, we can provide better pricing above discount from the end-supplier in each region, as well as increasing our top line and net revenue."
Chile Mining 2024
As the climate crisis deepens, Chile finds itself at a pivotal moment in its mining history.
Pascal Hamelin
CEO, ABCOURT MINES
"Our goal for the next few months is to begin small-scale production while we continue to drill and advance the engineering towards a pre-feasibility study."
Dato' Palaniappan Joseph
MANAGING DIRECTOR, SATAKE TECHNOLOGIES SDU BHD
"As industry and technologies evolve, the need for custom solutions and aftersales services has also become more prominent."
Septian Waluyan
PARTNER & COUNTRY MANAGER (INDONESIA), YCP SOLIDIANCE
"With the recent price fluctuations the industry is rather careful with what it spends on."
Chichi Emenike
ACTING MANAGING DIRECTOR, NECONDE ENERGY
"The plan is to increase both crude and gas production by working together with our JV partners."
Wole Ogunsanya
CHAIRMAN, PETROLEUM TECHNOLOGY ASSOCIATION OF NIGERIA (PETAN)
"PETAN advocates that authorities should look more into oil and gas evacuation on land and in swamp environments as the cost of production in these environments is approximately 20% of the production costs offshore."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
